Resources

The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies

Biomarkers in Immuno-Oncology

Rules Based Medicine: Operational Procedures

Rules-Based Medicine (RBM), a Q2 Solutions Company, has spent over 20 years developing and optimizing multiplex immunoassays based on the Luminex xMAP® technology.
Biomarkers in Immuno-Oncology

NeoGenomics: Transforming Care for Cancer Patients

Comprehensive service overview for pharmaceutical partners
Biomarkers in Immuno-Oncology

SyncroPatch 384 For All Your Patch Clamp Needs

Unprecedented flexibility for HTS automated patch clamp.
Biomarkers in Immuno-Oncology

Nanion: Cell Analytics Brochure

Next level live-cell kinetic and phenotypic assays.
Biomarkers in Immuno-Oncology

AtlaZ: Quantitative Live-Cell Analytics

Welcome to the next level of live-cell analytics.
Biomarkers in Immuno-Oncology

Hyperion XTi™ Imaging System

Uniquely designed for clinical research.
Biomarkers in Immuno-Oncology

Immune Cell-mediated Killing of A549 Cancer Target Cells in Real-time

Nanion Technologies GmbH, Munich. TUM, Munich
Therapeutic Modalities

Monitoring Cell – Attachment and Tightjunctions in the Same Assay

Nanion Technologies GmbH, Munich. University of Regensburg, Regensburg.
Therapeutic Modalities

SomaScan Panels

Big Insights. Targeted Data. Consistent Results.
Therapeutic Modalities

SomaScan®Assay v4.1

The SomaScan Platform is a powerful tool with applications in scientific research and health and wellness.
Therapeutic Modalities

SomaSignal® Tests

Multiple clinical assessments from a single blood draw.
Therapeutic Modalities

SomaScan Assay

A proteomics platform driving pioneering discoveries

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things immuno